FDA Inspection 1238380 — Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on Apr 5, 2024 in Fuzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fuzhou (China)